Alessandro Vitale
Alessandro Vitale
Surgeon, Azienda Ospedaliera Universitaria di Padova
Verified email at - Homepage
Cited by
Cited by
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
Prospective validation of the Barcelona Clinic Liver Cancer staging system
U Cillo, A Vitale, F Grigoletto, F Farinati, A Brolese, G Zanus, D Neri, ...
Journal of hepatology 44 (4), 723-731, 2006
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
U Cillo, A Vitale, M Bassanello, P Boccagni, A Brolese, G Zanus, P Burra, ...
Annals of Surgery 239 (2), 150, 2004
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
U Cillo, M Bassanello, A Vitale, FA Grigoletto, P Burra, S Fagiuoli, ...
Journal of hepatology 40 (1), 124-131, 2004
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ...
Journal of hepatology 66 (3), 552-559, 2017
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ...
The lancet oncology 12 (7), 654-662, 2011
Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?
G Spolverato, A Vitale, A Cucchetti, I Popescu, HP Marques, L Aldrighetti, ...
Cancer 121 (22), 3998-4006, 2015
Personalized treatment of patients with very early hepatocellular carcinoma
A Vitale, M Peck-Radosavljevic, EG Giannini, E Vibert, W Sieghart, ...
Journal of hepatology 66 (2), 412-423, 2017
Consensus conference on TIPS management: techniques, indications, contraindications
S Fagiuoli, R Bruno, WD Venon, F Schepis, F Vizzutti, P Toniutto, ...
Digestive and Liver Disease 49 (2), 121-137, 2017
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up‐to‐seven criteria
F D'Amico, M Schwartz, A Vitale, P Tabrizian, S Roayaie, S Thung, ...
Liver transplantation 15 (10), 1278-1287, 2009
Development and validation of a new prognostic system for patients with hepatocellular carcinoma
F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ...
PLoS Medicine 13 (4), e1002006, 2016
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria
U Cillo, A Vitale, F Grigoletto, E Gringeri, F D'amico, M Valmasoni, ...
American Journal of Transplantation 7 (4), 972-981, 2007
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost‐benefit analysis while awaiting data on sorafenib safety
A Vitale, ML Volk, D Pastorelli, S Lonardi, F Farinati, P Burra, P Angeli, ...
Hepatology 51 (1), 165-173, 2010
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation
A Cavallari, U Cillo, B Nardo, F Filipponi, E Gringeri, R Montalti, F Vistoli, ...
Liver Transplantation 9 (8), 814-821, 2003
Treatment of hepatocellular carcinoma in the precision medicine era: from treatment stage migration to therapeutic hierarchy
A Vitale, F Trevisani, F Farinati, U Cillo
Hepatology 72 (6), 2206-2218, 2020
Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer
Q Lai, A Vitale, S Iesari, A Finkenstedt, G Mennini, G Spoletini, ...
Hepatology 66 (6), 1910-1919, 2017
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ...
Journal of hepatology 60 (2), 290-297, 2014
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients
AW Avolio, U Cillo, M Salizzoni, L De Carlis, M Colledan, GE Gerunda, ...
American Journal of Transplantation 11 (12), 2724-2736, 2011
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries
U Baccarani, P Piselli, D Serraino, GL Adani, D Lorenzin, M Gambato, ...
Digestive and Liver Disease 42 (1), 55-60, 2010
The system can't perform the operation now. Try again later.
Articles 1–20